Back to Search
Start Over
Does XR injectable naltrexone prevent relapse as effectively as daily sublingual buprenorphine-naloxone?
- Source :
-
The Journal of family practice [J Fam Pract] 2020 Dec; Vol. 69 (10), pp. E14-E15. - Publication Year :
- 2020
-
Abstract
- YES. MONTHLY EXTENDED-RELEASE INJECTABLE NALTREXONE (XR-NTX) TREATS OPIOID USE DISORDER AS EFFECTIVELY AS DAILY SUBLINGUAL BUPRENORPHINE-NALOXONE (BUP-NX) WITHOUT CAUSING ANY INCREASE IN SERIOUS ADVERSE EVENTS OR FATAL OVERDOSES. (STRENGTH OF RECOMMENDATION: A, 2 GOOD-QUALITY RCTS).
- Subjects :
- Adult
Aged
Aged, 80 and over
Buprenorphine, Naloxone Drug Combination economics
Delayed-Action Preparations therapeutic use
Female
Humans
Male
Middle Aged
Narcotic Antagonists therapeutic use
Norway
United States
Administration, Sublingual
Buprenorphine, Naloxone Drug Combination administration & dosage
Buprenorphine, Naloxone Drug Combination therapeutic use
Delayed-Action Preparations administration & dosage
Injections, Intramuscular
Narcotic Antagonists administration & dosage
Opioid-Related Disorders drug therapy
Subjects
Details
- Language :
- English
- ISSN :
- 1533-7294
- Volume :
- 69
- Issue :
- 10
- Database :
- MEDLINE
- Journal :
- The Journal of family practice
- Publication Type :
- Academic Journal
- Accession number :
- 33348352